Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 800 of 1958 entries
View as:

A Study in Attention Deficit Hyperactivity Disorder in Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT01127646 Org: User:
Start: 06/30/10 End: 05/31/11 Due: 05/31/12

A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)

Phase: N/A Priority: Normal
NCT ID: NCT06948422 Org: User:
Start: 04/30/25 End: 09/30/27 Due: 09/30/28

A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1

Phase: N/A Priority: Normal
NCT ID: NCT06948435 Org: User:
Start: 04/30/25 End: 09/30/27 Due: 09/30/28

A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2

Phase: N/A Priority: Normal
NCT ID: NCT06952530 Org: User:
Start: 04/30/25 End: 09/30/27 Due: 09/30/28

A Study of LY3541105 in Healthy and Overweight Participants

Phase: N/A Priority: Normal
NCT ID: NCT05380323 Org: User:
Start: 05/10/22 End: 08/27/24 Due: 08/27/25

A Study of LY3532226 in Participants With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT05887999 Org: User:
Start: 06/12/23 End: 02/21/24 Due: 02/21/25

A Study of 2 Different Formulations of Blosozumab (LY2541546) in Post Menopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT02337387 Org: User:
Start: 01/31/15 End: 03/31/15 Due: 03/31/16

A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02747004 Org: User:
Start: 09/14/16 End: 12/31/25 Due: 12/31/26

Study of Ixekizumab in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03848403 Org: User:
Start: 01/29/19 End: 07/18/19 Due: 07/18/20

A Study to Compare Two Forms of LY2608204 in Healthy People

Phase: N/A Priority: Normal
NCT ID: NCT01313286 Org: User:
Start: 03/31/11 End: 04/30/11 Due: 04/30/12

A Study of LY3473329 in Healthy Japanese Participants

Phase: N/A Priority: Normal
NCT ID: NCT05038787 Org: User:
Start: 11/11/21 End: 04/07/22 Due: 04/07/23

A Study of Multiple Increasing Doses of LY2409021 in Participants With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01606397 Org: User:
Start: 03/31/08 End: 11/30/08 Due: 11/30/09

A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT05691712 Org: User:
Start: 02/05/23 End: 07/01/24 Due: 07/01/25

A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01784211 Org: User:
Start: 02/28/13 End: 11/30/13 Due: 11/30/14

A Study of Imlunestrant (LY3484356) in Female Participants With Impaired Liver Function

Phase: N/A Priority: Normal
NCT ID: NCT05440344 Org: User:
Start: 07/05/22 End: 02/28/24 Due: 02/28/25

A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria

Phase: N/A Priority: Normal
NCT ID: NCT04159701 Org: User:
Start: 11/15/19 End: 02/24/21 Due: 02/24/22

A Study of LY3050258 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01929707 Org: User:
Start: 08/31/13 End: 12/31/13 Due: 12/31/14

A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 In Participants With Osteoarthritis Pain

Phase: N/A Priority: Normal
NCT ID: NCT05620563 Org: User:
Start: 11/22/22 End: 06/12/23 Due: 06/12/24

A Study for Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00490854 Org: User:
Start: 07/31/07 End: 05/31/08 Due: 05/31/09

Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin

Phase: N/A Priority: Normal
NCT ID: NCT00036504 Org: User:
Start: 08/31/01 End: 08/31/02 Due: 08/31/03

A Study to Compare 2 Formulations of LY900014 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03334448 Org: User:
Start: 12/04/17 End: 03/15/18 Due: 03/15/19

A Study of LY900014 in Healthy Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT04049123 Org: User:
Start: 11/18/19 End: 10/23/20 Due: 10/23/21

A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02387814 Org: User:
Start: 03/31/15 End: 08/31/15 Due: 08/31/16

A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT04819100 Org: User:
Start: 12/20/21 End: 05/31/28 Due: 05/31/29

A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02564198 Org: User:
Start: 12/11/15 End: 07/16/19 Due: 07/16/20